Company intelligence / Profile preview

Diomics

San Diego, California, United States

Ownership: Private
Employees: ~25
Development stage: Other

Overview

Diomics develops both science-based and nature-based health products using its polymer-based Diomat platform; the company has launched immune-support and COVID-19 related wellness products (e.g. Diocare) but has not disclosed results from clinical-stage therapeutics.[2][4]

Therapeutic areas: ImmunologyInfectious DiseasesEndocrinologyNeurology
Modalities: DeviceBiologicDiagnosticsSmall molecule
Industry: Food & Nutrition

Partnerships

Bonne Santé Group

Beyond the preview

Go deeper on Diomics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Diomics.

Explore the full profile